准确测量和定量相关基质中可提示临床药物开发的许多方面的生物标志物。生物标志物分析可以为患者匹配合适的治疗,并证明候选药物的安全性和疗效,从而揭示其临床和商业成功的可能性。Q2 Solutions 提供广泛的定制和整合液相色谱质谱服务,以支持生物标志物测定和定量,包括液质联用 (LC/MS) 生物分析、LC/MS/MS 分析、混合 LC-MS 测定、小分子 LC/MS 和大分子生物分析。
This brochure highlights the specialty immunoassays performed by Rules-Based Medicine, a Q2 Solutions company. RBM provides an extensive menu of quantitative protein biomarkers, including multiplexed...
The increasing complexity of large molecule therapeutics has driven the need for additional approaches to quantitation in regulated bioanalysis where challenges with traditional ligand binding assays...
Presented at WRIB 2024 by Jing Liu, Principle Scientist, this poster looks at the challenges posed by XPro1595, a pegylated, engineered form of soluble human Tumor Necrosis Factor alpha (TNF alpha)...